Overview
GE HealthCare Technologies Inc., based in the United States, operates within the healthcare sector, primarily focusing on medical technology and digital solutions. As a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, GE Healthcare provides healthcare professionals and their patients with a comprehensive range of diagnostic, therapeutic, and monitoring products. The company is pivotal in enhancing precision health by delivering integrated solutions, including imaging, ultrasound, and informatics, alongside enterprise software and services used across diagnostics and monitoring. Key projects often involve collaborations with hospitals and research institutions aimed at advancing technologies such as AI-enhanced imaging systems and improving patient outcomes through more accurate and efficient diagnostic capabilities. GE HealthCare Technologies continues to be at the forefront of innovation in the healthcare industry, driving both technological advancement and accessible care.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for GE HealthCare Technologies Inc. as of June 30, 2025 is 19,967.00 MM.
- The operating income for GE HealthCare Technologies Inc. as of June 30, 2025 is 3,107.00 MM.
- The net income for GE HealthCare Technologies Inc. as of June 30, 2025 is 2,240.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 19,967.00 | 3,107.00 | 2,240.00 |
| 2025-03-31 | 19,799.00 | 3,088.00 | 2,183.00 |
| 2024-12-31 | 19,672.00 | 3,026.00 | 1,993.00 |
| 2024-09-30 | 19,558.00 | 2,846.00 | 1,675.00 |
| 2024-06-30 | 19,517.00 | 2,800.00 | 1,580.00 |
| 2024-03-31 | 19,495.00 | 2,779.00 | 1,570.00 |
| 2023-12-31 | 19,552.00 | 2,811.00 | 1,385.00 |
| 2023-09-30 | 19,284.00 | 2,819.00 | 1,536.00 |
| 2023-06-30 | 19,038.00 | 2,691.00 | 1,649.00 |
| 2023-03-31 | 18,705.00 | 2,632.00 | 1,716.00 |
| 2022-12-31 | 18,341.00 | 2,467.00 | 1,916.00 |
| 2022-09-30 | 17,992.00 | 2,477.00 | 1,926.00 |
| 2022-06-30 | 17,720.00 | 2,522.00 | 1,952.00 |
| 2022-03-31 | 17,582.00 | 2,597.00 | 2,051.50 |
| 2021-12-31 | 17,585.00 | 2,794.00 | 2,247.00 |
| 2020-12-31 | 17,164.00 | 2,716.00 | 13,846.00 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 4.37 | 4.34 |
| 2024-09-30 | 3.68 | 3.65 |
| 2024-06-30 | 3.47 | 3.45 |
| 2024-03-31 | 3.45 | 3.43 |
| 2023-12-31 | 3.05 | 3.03 |
| 2023-09-30 | 3.38 | 3.37 |
| 2023-06-30 | 3.63 | 3.62 |
| 2023-03-31 | 3.78 | 3.77 |
| 2022-12-31 | 4.22 | 4.22 |
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | 4.95 | 4.95 |
| 2020-12-31 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for GE HealthCare Technologies Inc. as of June 30, 2025 is 1,995.00 MM.
- The cash from investing activities for GE HealthCare Technologies Inc. as of June 30, 2025 is -1,007.00 MM.
- The cash from financing activities for GE HealthCare Technologies Inc. as of June 30, 2025 is 712.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 1,995.00 | -1,007.00 | 712.00 |
| 2025-03-31 | 1,782.00 | -1,133.00 | -706.00 |
| 2024-12-31 | 1,951.00 | -914.00 | -573.00 |
| 2024-09-30 | 2,088.00 | -762.00 | -196.00 |
| 2024-06-30 | 2,000.00 | -745.00 | -1,134.00 |
| 2024-03-31 | 2,052.00 | -480.00 | -1,304.00 |
| 2023-12-31 | 2,101.00 | -558.00 | -478.00 |
| 2023-09-30 | 2,093.00 | -565.00 | 385.00 |
| 2023-06-30 | 2,065.00 | -563.00 | -96.00 |
| 2023-03-31 | 2,113.00 | -564.00 | 271.00 |
| 2022-12-31 | 2,113.00 | -398.00 | -822.00 |
| 2022-09-30 | 1,060.00 | -1,835.00 | 616.00 |
| 2022-06-30 | 1,016.00 | -1,801.00 | 536.00 |
| 2022-03-31 | 1,555.00 | -1,788.50 | -143.50 |
| 2021-12-31 | 1,607.00 | -1,761.00 | -263.00 |
| 2020-12-31 | 1,687.00 | -323.00 | -2,166.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2020-12-31 |
Management Effectiveness
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | |||||
| 2025-03-31 | |||||
| 2024-12-31 | |||||
| 2024-09-30 | |||||
| 2024-06-30 | |||||
| 2024-03-31 | |||||
| 2023-12-31 | |||||
| 2023-09-30 | |||||
| 2023-06-30 | |||||
| 2023-03-31 | |||||
| 2022-12-31 | |||||
| 2022-09-30 | |||||
| 2022-06-30 | |||||
| 2022-03-31 | |||||
| 2021-12-31 | |||||
| 2020-12-31 | 0.92 | 0.01 | 0.11 |
Gross Margins
- The gross margin for GE HealthCare Technologies Inc. as of June 30, 2025 is 0.39.
- The net margin for GE HealthCare Technologies Inc. as of June 30, 2025 is 0.81.
- The operating margin for GE HealthCare Technologies Inc. as of June 30, 2025 is 0.16.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 0.39 | 0.81 | 0.16 |
| 2025-03-31 | 0.39 | 0.81 | 0.16 |
| 2024-12-31 | 0.39 | 0.81 | 0.16 |
| 2024-09-30 | 0.39 | 0.81 | 0.16 |
| 2024-06-30 | 0.39 | 0.81 | 0.16 |
| 2024-03-31 | 0.39 | 0.81 | 0.16 |
| 2023-12-31 | 0.39 | 0.81 | 0.16 |
| 2023-09-30 | 0.39 | 0.81 | 0.16 |
| 2023-06-30 | 0.39 | 0.81 | 0.16 |
| 2023-03-31 | 0.39 | 0.81 | 0.16 |
| 2022-12-31 | 0.39 | 0.81 | 0.16 |
| 2022-09-30 | 0.39 | 0.81 | 0.16 |
| 2022-06-30 | 0.39 | 0.81 | 0.16 |
| 2022-03-31 | 0.39 | 0.81 | 0.16 |
| 2021-12-31 | 0.39 | 0.81 | 0.16 |
| 2020-12-31 | 0.39 | 0.81 | 0.16 |
Identifiers and Descriptors
| Central Index Key (CIK) | 1932393 |
